OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
Charles Maisonneuve, Sylvie Bertholet, Dana J. Philpott, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 34, pp. 12294-12299
Open Access | Times Cited: 279
Charles Maisonneuve, Sylvie Bertholet, Dana J. Philpott, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 34, pp. 12294-12299
Open Access | Times Cited: 279
Showing 1-25 of 279 citing articles:
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 6, pp. 454-475
Open Access | Times Cited: 967
Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 6, pp. 454-475
Open Access | Times Cited: 967
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 890
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 890
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Roberta Caruso, Neil Warner, Naohiro Inohara, et al.
Immunity (2014) Vol. 41, Iss. 6, pp. 898-908
Open Access | Times Cited: 705
Roberta Caruso, Neil Warner, Naohiro Inohara, et al.
Immunity (2014) Vol. 41, Iss. 6, pp. 898-908
Open Access | Times Cited: 705
Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 440
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 440
Basic concepts and recent advances in nanogels as carriers for medical applications
Iordana Neamţu, Alina Gabriela Rusu, Alina Diaconu, et al.
Drug Delivery (2017) Vol. 24, Iss. 1, pp. 539-557
Open Access | Times Cited: 390
Iordana Neamţu, Alina Gabriela Rusu, Alina Diaconu, et al.
Drug Delivery (2017) Vol. 24, Iss. 1, pp. 539-557
Open Access | Times Cited: 390
Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 328
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 328
Outer membrane vesicles as platform vaccine technology
Leo van der Pol, Michiel Stork, Peter van der Ley
Biotechnology Journal (2015) Vol. 10, Iss. 11, pp. 1689-1706
Open Access | Times Cited: 322
Leo van der Pol, Michiel Stork, Peter van der Ley
Biotechnology Journal (2015) Vol. 10, Iss. 11, pp. 1689-1706
Open Access | Times Cited: 322
Vaccines, new opportunities for a new society
Rino Rappuoli, Mariagrazia Pizza, Giuseppe Del Giudice, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 34, pp. 12288-12293
Open Access | Times Cited: 310
Rino Rappuoli, Mariagrazia Pizza, Giuseppe Del Giudice, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 34, pp. 12288-12293
Open Access | Times Cited: 310
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Bacterial Outer Membrane Vesicles: From Discovery to Applications
Mariana G. Sartorio, Evan J. Pardue, Mario F. Feldman, et al.
Annual Review of Microbiology (2021) Vol. 75, Iss. 1, pp. 609-630
Open Access | Times Cited: 216
Mariana G. Sartorio, Evan J. Pardue, Mario F. Feldman, et al.
Annual Review of Microbiology (2021) Vol. 75, Iss. 1, pp. 609-630
Open Access | Times Cited: 216
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
S. Schmidt, Camilla Foged, Karen Smith Korsholm, et al.
Pharmaceutics (2016) Vol. 8, Iss. 1, pp. 7-7
Open Access | Times Cited: 193
S. Schmidt, Camilla Foged, Karen Smith Korsholm, et al.
Pharmaceutics (2016) Vol. 8, Iss. 1, pp. 7-7
Open Access | Times Cited: 193
Combating Implant Infections: Shifting Focus from Bacteria to Host
Saber Amin Yavari, Suzanne M. Castenmiller, Jos A. G. van Strijp, et al.
Advanced Materials (2020) Vol. 32, Iss. 43
Open Access | Times Cited: 185
Saber Amin Yavari, Suzanne M. Castenmiller, Jos A. G. van Strijp, et al.
Advanced Materials (2020) Vol. 32, Iss. 43
Open Access | Times Cited: 185
Development of the CpG Adjuvant 1018: A Case Study
John D. Campbell
Methods in molecular biology (2016), pp. 15-27
Closed Access | Times Cited: 173
John D. Campbell
Methods in molecular biology (2016), pp. 15-27
Closed Access | Times Cited: 173
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 145
Samantha Paston, Victoria A. Brentville, Peter Symonds, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 145
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 126
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 126
Development of Peptide-Based Vaccines for Cancer
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 93
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 93
A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2
Qian Yin, Wei Luo, Vamsee Mallajosyula, et al.
Nature Materials (2023)
Open Access | Times Cited: 59
Qian Yin, Wei Luo, Vamsee Mallajosyula, et al.
Nature Materials (2023)
Open Access | Times Cited: 59
Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination
Elana Ben‐Akiva, Johan Karlsson, Shayan Hemmati, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 26
Open Access | Times Cited: 58
Elana Ben‐Akiva, Johan Karlsson, Shayan Hemmati, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 26
Open Access | Times Cited: 58
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
Shujing Wang, Huiqin Liu, Xinyi Zhang, et al.
Protein & Cell (2015) Vol. 6, Iss. 7, pp. 480-503
Open Access | Times Cited: 138
Shujing Wang, Huiqin Liu, Xinyi Zhang, et al.
Protein & Cell (2015) Vol. 6, Iss. 7, pp. 480-503
Open Access | Times Cited: 138
Immunological off-target effects of imatinib
Laurence Zitvogel, Sylvie Rusakiewicz, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 7, pp. 431-446
Closed Access | Times Cited: 133
Laurence Zitvogel, Sylvie Rusakiewicz, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 7, pp. 431-446
Closed Access | Times Cited: 133
Advancements in prophylactic and therapeutic nanovaccines
Prateek Bhardwaj, Eshant Bhatia, Shivam Sharma, et al.
Acta Biomaterialia (2020) Vol. 108, pp. 1-21
Open Access | Times Cited: 126
Prateek Bhardwaj, Eshant Bhatia, Shivam Sharma, et al.
Acta Biomaterialia (2020) Vol. 108, pp. 1-21
Open Access | Times Cited: 126
Chemical Strategies to Boost Cancer Vaccines
Wenhao Li, Yanmei Li
Chemical Reviews (2020) Vol. 120, Iss. 20, pp. 11420-11478
Closed Access | Times Cited: 126
Wenhao Li, Yanmei Li
Chemical Reviews (2020) Vol. 120, Iss. 20, pp. 11420-11478
Closed Access | Times Cited: 126
Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses
Stephen N. Crooke, Inna G. Ovsyannikova, Gregory A. Poland, et al.
Experimental Gerontology (2019) Vol. 124, pp. 110632-110632
Open Access | Times Cited: 123
Stephen N. Crooke, Inna G. Ovsyannikova, Gregory A. Poland, et al.
Experimental Gerontology (2019) Vol. 124, pp. 110632-110632
Open Access | Times Cited: 123
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
Diletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.
PLoS ONE (2016) Vol. 11, Iss. 8, pp. e0161193-e0161193
Open Access | Times Cited: 119
Diletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.
PLoS ONE (2016) Vol. 11, Iss. 8, pp. e0161193-e0161193
Open Access | Times Cited: 119
Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice
C. Garrett Rappazzo, Hannah C. Watkins, Cassandra Guarino, et al.
Vaccine (2016) Vol. 34, Iss. 10, pp. 1252-1258
Closed Access | Times Cited: 118
C. Garrett Rappazzo, Hannah C. Watkins, Cassandra Guarino, et al.
Vaccine (2016) Vol. 34, Iss. 10, pp. 1252-1258
Closed Access | Times Cited: 118
